Status:
UNKNOWN
A Trial of Norethisterone Acetate and Expectant Management in Treatment of Simple Ovarian Cysts
Lead Sponsor:
Assiut University
Conditions:
Ovarian Cyst Simple
Eligibility:
FEMALE
24-49 years
Phase:
PHASE4
Brief Summary
To compare the effectiveness of (norethisterone acetate) in the treatment of spontaneously occurring simple ovarian cyst detected by ultrasonography compared with expectant management.
Detailed Description
An ovarian cyst is a sac filled with liquid or semiliquid material that arises in an ovary. The number of diagnoses of ovarian cysts has increased with the widespread implementation of regular physica...
Eligibility Criteria
Inclusion
- women at age 24-49 years old
- women with simple cyst.( with none of the following: solid parts, papillary formations, peritoneal masses, intraabdominal lymph node enlargement or ascites ) .(13)
- from 5 to10cm in diameter.
- functioning cyst.( defined as largest dimension between 2-8 cm in diameter, unilateral, uniloculated, thin-walled, anechogenic and has distal acoustic enhancement )
Exclusion
- premenarche
- postmenopause
- current user of Norethisterone acetate.
- those having contraindication from Norethisterone use.
- gynecologic malignancy
Key Trial Info
Start Date :
October 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT05293574
Start Date
October 1 2022
End Date
December 1 2023
Last Update
March 24 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.